Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Non-Steroidal Anti-Inflammatory Drugs Increase Cisplatin, Paclitaxel, and Doxorubicin Efficacy against Human Cervix Cancer Cells
Diana Xochiquetzal Robledo‐Cadena, Juan Carlos Gallardo‐Pérez, Víctor Manuel Dávila‐Borja, et al.
Pharmaceuticals (2020) Vol. 13, Iss. 12, pp. 463-463
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Inflammation and tumor progression: signaling pathways and targeted intervention
Huakan Zhao, Lei Wu, Guifang Yan, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 1653
Artificial intelligence to deep learning: machine intelligence approach for drug discovery
Rohan Gupta, Devesh Srivastava, Mehar Sahu, et al.
Molecular Diversity (2021) Vol. 25, Iss. 3, pp. 1315-1360
Open Access | Times Cited: 932
Sodium alginate based drug delivery in management of breast cancer
Mohammad Arshad Javed Shaikh, Khalid Saad Alharbi, Waleed Hassan Almalki, et al.
Carbohydrate Polymers (2022) Vol. 292, pp. 119689-119689
Closed Access | Times Cited: 96
Metal Complexes in Cancer Treatment: Journey So Far
Ankit Kumar Singh, Adarsh Kumar, Harshwardhan Singh, et al.
Chemistry & Biodiversity (2023) Vol. 20, Iss. 4
Closed Access | Times Cited: 43
Design, synthesis, and cytotoxicity of ibuprofen-appended benzoxazole analogues against human breast adenocarcinoma
Vishnu Thumma, Veerabhadraiah Mallikanti, Raghavender Matta, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 4, pp. 1283-1294
Closed Access | Times Cited: 17
NSAIDs: Old Acquaintance in the Pipeline for Cancer Treatment and Prevention─Structural Modulation, Mechanisms of Action, and Bright Future
Sandra Ramos-Inza, Ana Carolina Ruberte, Carmen Sanmartín, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 22, pp. 16380-16421
Closed Access | Times Cited: 42
Cancer-associated inflammation: pathophysiology and clinical significance
Piotr Pęczek, Monika Gajda, Kacper Rutkowski, et al.
Journal of Cancer Research and Clinical Oncology (2022) Vol. 149, Iss. 6, pp. 2657-2672
Open Access | Times Cited: 36
Design, synthesis and anticancer activity of 5-((2-(4-bromo/chloro benzoyl) benzofuran-5-yl) methyl)-2-((1-(substituted)-1H-1,2,3-triazol-4-yl)methoxy)benzaldehyde analogues
Vishnu Thumma, M. Veerabhadraiah, V. Krishna Chaitanya, et al.
Molecular Diversity (2022) Vol. 27, Iss. 6, pp. 2695-2713
Closed Access | Times Cited: 28
Enhanced cytotoxic effect of doxorubicin conjugated gold nanoparticles on breast cancer model
Amna H. Faid, Samia A. Shouman, Yehia Badr, et al.
BMC Chemistry (2022) Vol. 16, Iss. 1
Open Access | Times Cited: 26
Targeting the redox imbalance in mitochondria: A novel mode for cancer therapy
Shalini Mani, Geeta Swargiary, Stephen J. Ralph
Mitochondrion (2021) Vol. 62, pp. 50-73
Closed Access | Times Cited: 31
Design, synthesis of benzimidazole tethered 3,4-dihydro-2H-benzo[e] [1, 3] oxazines as anticancer agents
Srinivas Gali, Dinesh Raghu, Veerabhadraiah Mallikanti, et al.
Molecular Diversity (2023) Vol. 28, Iss. 3, pp. 1347-1361
Closed Access | Times Cited: 11
Design, Synthesis of Novel 1,2,3‐Triazole Pendent Quinazolinones and Their Cytotoxicity against MCF‐7 Cell Line
Nagaraju Myakala, Kotaiah Kandula, Nagamani Rayala, et al.
Chemistry & Biodiversity (2023) Vol. 20, Iss. 12
Closed Access | Times Cited: 11
Hyaluronic Acid-Modified and Doxorubicin-Loaded Gold Nanoparticles and Evaluation of Their Bioactivity
Linsong Li, Bin Ren, Xiaojing Yang, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 2, pp. 101-101
Open Access | Times Cited: 27
Modeling Krebs cycle from liver, heart and hepatoma mitochondria, supported Complex I as target for specific inhibition of cancer cell proliferation
Luz Hernández‐Esquivel, Isis Del Mazo‐Monsalvo, Silvia Cecilia Pacheco-Velázquez, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Anticancer Activity and Mechanism of Action Evaluation of an Acylhydrazone Cu(II) Complex toward Breast Cancer Cells, Spheroids, and Mammospheres
Lucía M. Balsa, María R. Rodríguez, Beatriz S. Parajón‐Costa, et al.
ChemMedChem (2021) Vol. 17, Iss. 4
Closed Access | Times Cited: 22
Fine particulate matter (PM2.5) promotes chemoresistance and aggressive phenotype of A549 lung cancer cells
Zaira Colín-Val, Guillermo Flores-Navarro, Leticia Rocha‐Zavaleta, et al.
Toxicology and Applied Pharmacology (2024) Vol. 487, pp. 116955-116955
Closed Access | Times Cited: 3
Silver(I) Complexes with Mefenamic Acid and Nitrogen Heterocyclic Ligands: Synthesis, Characterization, and Biological Evaluation
Lulin Zhang, Xiang Huang, Mohammad Azam, et al.
Inorganic Chemistry (2024) Vol. 63, Iss. 27, pp. 12624-12634
Closed Access | Times Cited: 3
Assessing Therapeutic Value and Side Effects of Key Botanical Compounds for Optimized Medical Treatments
Mohammed Baqur S. Al‐Shuhaib, Jafar M. B. Al‐Shuhaib
Chemistry & Biodiversity (2024)
Closed Access | Times Cited: 3
Putative Repurposing of Lamivudine, a Nucleoside/Nucleotide Analogue and Antiretroviral to Improve the Outcome of Cancer and COVID-19 Patients
José J. García‐Trejo, Raquel Ortega, Mariel Zarco‐Zavala
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 20
Effect of celecoxib plus standard chemotherapy on cancer prognosis: A systematic review and meta‐analysis
Liangyu Li, Yingrui Zhang, Lizheng Qin
European Journal of Clinical Investigation (2023) Vol. 53, Iss. 6
Closed Access | Times Cited: 8
Discovery and optimization of 2,3-diaryl-1,3-thiazolidin-4-one-based derivatives as potent and selective cytotoxic agents with anti-inflammatory activity
Ahmed M. Shawky, Faisal A. Almalki, Ashraf N. Abdalla, et al.
European Journal of Medicinal Chemistry (2023) Vol. 259, pp. 115712-115712
Closed Access | Times Cited: 7
3D-Printing of Capsule Devices as Compartmentalization Tools for Supported Reagents in the Search of Antiproliferative Isatins
Camilla Malatini, Carlos Carbajales, Mariángel Luna, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 2, pp. 310-310
Open Access | Times Cited: 4
17-β Estradiol up-regulates energy metabolic pathways, cellular proliferation and tumor invasiveness in ER+ breast cancer spheroids
Silvia Cecilia Pacheco-Velázquez, Ingrid Itzayanna Ortega-Mejía, Jorge Luis Vargas-Navarro, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 7
Blockade of store-operated calcium entry sensitizes breast cancer cells to cisplatin therapy via modulating inflammatory response
Abdullah S. Alhamed, Mohammed Alqinyah, Musab A. Alsufayan, et al.
Saudi Pharmaceutical Journal (2022) Vol. 31, Iss. 2, pp. 245-254
Open Access | Times Cited: 7
Improved Anticancer Activity of Doxorubicin Gold Nanohybrid on Breast Cell Line
Amna H. Faid, Elham M. Mostafa, Marwa A. Ramadan
International Journal of Advances Engineering and Civil Research/International Journal of Mechanical Engineering and Applied Energy (2022) Vol. 2, Iss. 1, pp. 36-47
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top